ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/13 | 4,250 | 4,400 | 4,240 | 4,380 | +165 | +3.9% | 608,700 |
2018/07/12 | 4,255 | 4,340 | 4,195 | 4,215 | -55 | -1.3% | 563,300 |
2018/07/11 | 4,315 | 4,380 | 4,235 | 4,270 | -145 | -3.3% | 704,000 |
2018/07/10 | 4,370 | 4,430 | 4,345 | 4,415 | +90 | +2.1% | 1,063,500 |
2018/07/09 | 4,150 | 4,360 | 4,150 | 4,325 | +215 | +5.2% | 952,400 |
2018/07/06 | 4,055 | 4,160 | 4,020 | 4,110 | +70 | +1.7% | 1,114,200 |
2018/07/05 | 4,030 | 4,070 | 3,960 | 4,040 | -30 | -0.7% | 1,019,000 |
2018/07/04 | 4,050 | 4,105 | 3,840 | 4,070 | +35 | +0.9% | 1,424,800 |
2018/07/03 | 4,145 | 4,275 | 3,990 | 4,035 | -145 | -3.5% | 1,627,100 |
2018/07/02 | 4,610 | 4,635 | 4,145 | 4,180 | -430 | -9.3% | 2,088,800 |
2018/06/29 | 4,560 | 4,640 | 4,470 | 4,610 | +40 | +0.9% | 665,600 |
2018/06/28 | 4,495 | 4,580 | 4,475 | 4,570 | +85 | +1.9% | 755,500 |
2018/06/27 | 4,510 | 4,565 | 4,460 | 4,485 | -95 | -2.1% | 783,100 |
2018/06/26 | 4,620 | 4,645 | 4,495 | 4,580 | -85 | -1.8% | 841,100 |
2018/06/25 | 5,030 | 5,070 | 4,645 | 4,665 | -335 | -6.7% | 1,202,300 |
2018/06/22 | 4,945 | 5,030 | 4,915 | 5,000 | +25 | +0.5% | 683,600 |
2018/06/21 | 4,950 | 4,990 | 4,905 | 4,975 | +20 | +0.4% | 601,700 |
2018/06/20 | 4,775 | 4,960 | 4,770 | 4,955 | +140 | +2.9% | 682,900 |
2018/06/19 | 4,940 | 4,945 | 4,780 | 4,815 | -95 | -1.9% | 712,000 |
2018/06/18 | 4,835 | 4,930 | 4,730 | 4,910 | +45 | +0.9% | 944,900 |
2018/06/15 | 4,935 | 5,000 | 4,855 | 4,865 | -55 | -1.1% | 677,700 |
2018/06/14 | 4,950 | 5,020 | 4,890 | 4,920 | -75 | -1.5% | 650,100 |
2018/06/13 | 4,955 | 5,030 | 4,935 | 4,995 | +35 | +0.7% | 855,500 |
2018/06/12 | 4,830 | 4,965 | 4,810 | 4,960 | +170 | +3.5% | 1,379,300 |
2018/06/11 | 4,685 | 4,795 | 4,685 | 4,790 | +125 | +2.7% | 650,500 |
2018/06/08 | 4,605 | 4,725 | 4,600 | 4,665 | +105 | +2.3% | 921,800 |
2018/06/07 | 4,445 | 4,585 | 4,410 | 4,560 | +140 | +3.2% | 1,003,000 |
2018/06/06 | 4,460 | 4,460 | 4,340 | 4,420 | -85 | -1.9% | 829,800 |
2018/06/05 | 4,570 | 4,645 | 4,470 | 4,505 | -135 | -2.9% | 1,022,700 |
2018/06/04 | 4,750 | 4,775 | 4,615 | 4,640 | -140 | -2.9% | 963,600 |
2018/06/01 | 4,750 | 4,885 | 4,730 | 4,780 | +50 | +1.1% | 1,236,200 |
2018/05/31 | 4,645 | 4,770 | 4,615 | 4,730 | +125 | +2.7% | 1,399,700 |
2018/05/30 | 4,575 | 4,630 | 4,505 | 4,605 | -45 | -1% | 752,500 |
2018/05/29 | 4,660 | 4,700 | 4,515 | 4,650 | -25 | -0.5% | 816,600 |
2018/05/28 | 4,745 | 4,760 | 4,615 | 4,675 | -75 | -1.6% | 667,400 |
2018/05/25 | 4,805 | 4,860 | 4,715 | 4,750 | -50 | -1% | 1,135,400 |
2018/05/24 | 4,675 | 4,805 | 4,660 | 4,800 | +85 | +1.8% | 985,300 |
2018/05/23 | 4,790 | 4,805 | 4,625 | 4,715 | -20 | -0.4% | 1,446,100 |
2018/05/22 | 4,580 | 4,750 | 4,570 | 4,735 | +210 | +4.6% | 1,578,200 |
2018/05/21 | 4,520 | 4,580 | 4,510 | 4,525 | +5 | +0.1% | 629,300 |
2018/05/18 | 4,510 | 4,650 | 4,465 | 4,520 | +130 | +3% | 1,350,500 |
2018/05/17 | 4,520 | 4,520 | 4,380 | 4,390 | -130 | -2.9% | 1,062,900 |
2018/05/16 | 4,460 | 4,535 | 4,420 | 4,520 | -10 | -0.2% | 705,400 |
2018/05/15 | 4,490 | 4,600 | 4,400 | 4,530 | +170 | +3.9% | 1,453,900 |
2018/05/14 | 4,350 | 4,415 | 4,310 | 4,360 | +15 | +0.3% | 825,400 |
2018/05/11 | 4,365 | 4,375 | 4,255 | 4,345 | -45 | -1% | 706,900 |
2018/05/10 | 4,385 | 4,525 | 4,360 | 4,390 | +45 | +1% | 1,142,400 |
2018/05/09 | 4,625 | 4,645 | 4,305 | 4,345 | -360 | -7.7% | 1,863,100 |
2018/05/08 | 4,500 | 4,730 | 4,490 | 4,705 | +250 | +5.6% | 1,493,900 |
2018/05/07 | 4,550 | 4,550 | 4,385 | 4,455 | -40 | -0.9% | 789,500 |
1651~
1700
件表示中 / 2899件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,600円 | +5.0% | +1.5% | 0.00% | 16.10倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 357,000円 | +7.9% | +8.9% | 3.47% | 7.64倍 | 1.02倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 62,700円 | +21.1% | - | 0.00% | 15.57倍 | 2.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 410,900円 | +30.5% | +111.0% | 4.62% | 11.58倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 378,000円 | +14.5% | -2.3% | 2.38% | 13.83倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム